- Past Issues
- e-Submission
-
2021 Impact Factor 1.766
5-Year Impact Factor 1.674
Editorial Office
- +82-01-9989-7744
- kbiolpsychiatry@gmail.com
- https://www.biolpsychiatry.or.kr/
2021 Impact Factor 1.766
5-Year Impact Factor 1.674
Korean Journal of Biological Psychiatry 2009;16(2):121-6. Published online: Feb, 1, 2009
Objectives:The serotonin transporter
gene(SLC6A4) is one of the most widely
studied candidate genes in autism spectrum disorder(ASD), but there have been
conflicting results from studies into the association between SLC6A4 and ASD.
The aim of this study was to evaluate the association between single nucleotide
polymorphisms(SNPs) in the SLC6A4 gene and ASD in the Korean population.
Methods:We selected 12 SNPs in SLC6A4 and observed the genotype of 151 Korean
ASD trios. We tested the family-based association for each individual
polymorphism and haplotype by using the standard TDT method in
Haploview(http://www.broad.mit.edu/mpg/haploview/).
Results:Through transmission-disequilibrium testing and haplotype analysis, we
could not find any statistically significant transmitted allele or haplotype. In
addition, a case-control association test with Korean HapMap data did not reveal
any statistical significance.
Conclusion:Although serotonin-related genes must be considered candidate genes
for ASD, we suggest that common SNPs of SLC6A4 are not important markers for
associations with Korean ASD.
Keywords Autistic disorders;Serotonin transporter;Genetic polymorphism;Haplotypes;Association.
교신저자:김순애, 301-746 대전광역시 중구 용두동 143-5
책임저자:전화) (042) 259-1672, 전송) (042) 259-1668, E-mail) sakim@eulji.ac.kr
Autism spectrum disorders(ASDs) are neuropsychiatric developmental disorders
characterized by impairment in social communication and a preference for
repetitive and solitary interests and behaviors. Several family and twin studies
have reported the role of genetics in the etiology of autism.1) In association
genetic studies for ASDs, several neurotransmitter genes such as
serotonin-related genes are considered as candidate genes because of the
possible involvement of neurochemical effects in pathogenesis of ASDs.
Serotonin(5-hydroxytryptamine or 5-HT) has been considered to play an important
role in ASD development. A relatively high platelet serotonin level was observed
in a subset of ASD subjects and their first-degree relatives2);the blood
serotonin level was also found to correlate with the verbal intelligence
quotient(IQ) and the severity of the disorder.3)4)5) The use of selective
serotonin reuptake inhibitor drugs(SSRIs) was found to improve some symptoms
such as repetitive behavior, aggression, and language use in individuals with
autistic disorder.6)7)8) Numerous genes, for example, the serotonin transporter
gene, the tryptophan hydroxylase gene, and the monoamine oxidase A gene, are
involved in regulating serotonin levels, and some of them have been screened in
ASD individuals.9)10)11)12)
The serotonin transporter is a major component of the serotonergic system and is
thought to play a role in autism pathogenesis. The serotonin transporter gene (SLC6A4) is one of the most widely studied candidate genes for ASD;it is located
in chromosome 17q11.2 and has 14 exons. Several linkage studies and genome-wide
screening studies have found evidence of a linkage near the serotonin
transporter gene.13)14)15) Some studies have also reported an association between
autism and polymorphic markers in the SLC6A4 gene, such as 5-HTTLPR
insertion-deletion polymorphisms in the promoter region. The association between
the 5-HTTLPR polymorphism of SLC6A4 and ASD has produced controversial results
that touch upon ethnic diversity, methods of genetic analysis, and symptom
profiles of ASD.9)14)16)17)18)19)20) It is suggested that hyperserotonemia in ASD may be
associated with the effects of regulation and expression of SLC6A4 via the
5-HTTLPR promoter polymorphism.21)22) The results of the association analysis
using single nucleotide polymorphisms(SNPs) of SLC6A4(i.e., rs2020 942,
rs2066713, and rs2020936) in several studies were controversial. Kim et al.17)
reported an association between autism and these SNPs in 115 trios examined, but
their results were not consistent with those of McCauley et al.14) or Wu et
al.23) In their extensive study with large cohort samples, Ramoz et al.24)
reported the absence of a linkage or association with 9 SNPs and 5-HTTLPR
covering SLC6A4 or any haplotypes.
By using the transmission/disequilibrium test(TDT), we found a significant
preferential transmission of the long allele of 5-HTTLPR in Korean ASD.25) To
further investigate the role of SLC6A4 in susceptibility of Korean population to
ASD, we evaluated the association between ASD and common SNPs of SLC 6A4 by
using 151 ASD trios in the Korean population.
Methods
1. Subjects
The subjects were recruited from a family-based genetic
association study of ASD conducted by the same research group.25)26) Subject ascertainment and diagnostic
methods have been described previously. Briefly, ASD was diagnosed using the
Autism Diagnostic Interview-Revised(ADI-R)27) and the Korean version of the
Autism Diagnostic Observation Schedule(ADOS)28) with the best estimates of 2
board-certified child psychiatrists. Subjects diagnosed to have or strongly
suspected of having neurofibromatosis, tuberous sclerosis, metabolic
encephalopathies, Down's syndrome, Fragile X syndrome, or other known
chromosomal abnormalities were excluded. We obtained written informed consent
from all participants, and the study was approved by the Institutional Review
Boards(IRB) of the participating institutions. This study included 151 complete
trios, consisting of patients with ASD(79.9±35.6 months, 86.1% males, 87.4%
autism, 13.5% Pervasive Developmental Disorder-Not Otherwise Specified(PDD-NOS),
and 1.6% Asperger's disorder) and their biological parents. Their psychological
characteristics were almost similar, as described previously.26)
For a case-control association study, we used Korean HapMap project data of 7
SNPs(rs3813034, rs 1042173, rs6352, rs140701, rs2020942, rs6354, and rs2020936)
in the SLC6A4 gene from 90 Korean adult samples with a 1:1 male to female
ratio(http: //sysbio.kribb.re.kr:8080/khapmap/index.jsp).
2. Genotyping
Blood samples from all subjects were collected in tubes containing EDTA and
stored at -70℃. Genomic DNA was extracted using the G-spin Genomic DNA
Extraction Kit(Intron, Daejeon, Korea).
We evaluated the genetic structure of SLC6A4 by using the Entrez SNP
Database(http://www.ncbi.nlm. nih.gov/) and determined SNP in the coding region
(cSNP) and a common genetic variation of SLC6A4 (i.e., SNPs in the gene region
with minor allele frequencies >5% in 2 Asian populations). We selected 5
cSNPs(rs6352, rs28914834, rs28914832, rs2228673, and rs28914828), 4 SNPs in the
intronic regions(rs 3794808, rs140701, rs2020942, and rs2020936), 1 SNP in the
5'-untranslated region(rs6354), 1 SNP in the 3'-untranslated region(rs1042173),
and 1 SNP in the 3'-near gene region(rs3813034) of SLC6A4. Genotyping was
performed using the GoldenGateTM assay(Illumina, San Diego, USA).
3. Statistical analysis
To evaluate the data quality and the presence of genotypic errors, we evaluated
the Hardy-Weinberg equilibrium and Mendelian inheritance of the genotypes within
the trios. We tested the family-based association for each individual
polymorphism and haplotype by using the standard TDT method in
Haploview(http://www.broad.mit.edu/mpg/haploview/). Statistical significance was
defined as p<0.05.
To evaluate the power of the samples to detect an excessive transmission of
alleles, we used the program PBAT.29) We assume that autism prevalence to be
K=0.006, with a targeted significance level of 0.05. In terms of the frequency
of the disease allele, we used observed frequency of the highly transmitted
allele and we employed the additive model.
Tests to compare the alleles, genotypes and haplotype frequencies of cases with
those of Korean Hap Map controls were conducted using SNPAlyze 5.0.4 (Dynacom,
Chiba, Japan).
Results
The genotypic distribution for all the SNPs did not deviate from that expected
based on the Hardy-Weinberg equilibrium. Four cSNPs(rs28914834, rs2891 4832,
rs2228673, and rs28914828) were monomorphic. Information on these SNPs is given
in Table 1. In the TDT analysis, we did not find any statistically significant
overtransmitted SNP alleles in the ASDs (Table 2). Estimation of the pairwise
linkage disequilibrium(LD) to determine the extent of LD for the SNPs showed
that all the SNPs were in strong disequilibrium(D'>0.9) with each other(Table 3). Because of strong LDs among the SNP markers, in the haplotype analysis, we
found only 3 haplotypes consisting of 7 SNPs in SLC6A4, and we did not observe
any significant association between the haplotypes and ASD(Table 2).
We used an odds ratio(OR) of 1.7 for carrying one disease allele. Considering
the prevalence of ASD in 0.6% of general population, the power of TDT for rs
1042173, rs6352, rs3794808, rs6354, and rs2020936 was 0.373, 0.131, 0.378,
0.218, and 0.218, respectively. A type I error rate of 0.05 was used in all
calculations.
In the case-control association analysis, we did not observe any statistically
significant differences in allele, genotype, and haplotype frequencies between
our ASD cases and the Korean HapMap controls(Table 4).
Discussion
Several previous reports have indicated the possibility of a linkage and/or
association between SLC6A4 and ASD. Kim et al.17) revealed an association
between autism and SNPs of SLC6A4 in 115 trios. However, studies involving TDTs
have failed to reveal any consistent evidence of this association. In the
present study, we did not observe any statistically significant transmission
from biological parents to Korean ASD children with more SNPs(i.e., 12 SNPs in
the SLC 6A4 gene, of which 8 SNPs were analyzed with statistical tools) in the
TDT and haplotype analysis. Moreover, the power values of our study were very
small, and our study has potential limitations with regard to detection of
causative variants or variants with more modest effects. Furthermore, the
control subjects were not age and sex matched with the study subjects, and
psychiatric disorders in the control subjects were not evaluated. Nonetheless,
the results of the case-control analysis did not reveal any statistically
significant results.
The reason for these differences in association results might be as follows.
First, ethnic differences might contribute to different genetic associations.
This study included only Asian Korean population, similar to the study of Wu et
al.(175 Han Chinese trios)23);thus, the sample population differed from that
used in the study by Kim et al.(94 Caucasians, 7 Americans, 8 Asian Americans,
and 6 Hispanics).17) Second, the sample size of the study by Kim et al. was
relatively small compared to that of our study. Therefore, the results of the
study by Kim et al need to be considered. Finally, the genetic heterogeneity of
ASDs and the possibility of involvement of other genes or environmental factors
such as gene-gene interaction or gene-environmental interaction must be
considered.
Although our study had certain limitations such as relatively small sample size
and a lack of information on phenotypes and environmental risk factors, our
findings suggest that common SNPs(minor allele frequency of more than 0.01) and
haplotypes for SLC6A4 do not appear to significantly contribute to ASD in the
Korean population. Nonetheless, we believe that the association study of the
5-HTTLPR(not SNPs) marker for SLC6A4 must be replicated in a larger Korean
population, together with a phenotypic analysis, because of its functional
effects and a previous report on positive association.25)
Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995;25:63-77.
Cross S, Kim SJ, Weiss LA, Delahanty RJ, Sutcliffe JS, Leventhal BL, et al. Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism. Neuropsychopharmacology 2008;33:353-360.
Abramson RK, Wright HH, Carpenter R, Brennan W, Lumpuy O, Cole E, et al. Elevated blood serotonin in autistic probands and their first-degree relatives. J Autism Dev Disord 1989;19:397-407.
Anderson GM, Freedman DX, Cohen DJ, Volkmar FR, Hoder EL, McPhedran P, et al. Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry 1987;28:885-900.
Cook EH, Leventhal BL. The serotonin system in autism. Curr Opin Pediatr 1996;8:348-354.
Anderson GM. Genetics of childhood disorders: XLV. Autism, part 4: serotonin in autism. J Am Acad Child Adolesc Psychiatry 2002;41:1513-1516.
Gordon CT, State RC, Nelson JE, Hamburger SD, Rapoport JL. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry 1993;50:441-447.
McDougle CJ, Naylor ST, Cohen DJ, Volkmar FR, Heninger GR, Price LH. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 1996;53:1001-1008.
Persico AM, Pascucci T, Puglisi-Allegra S, Militerni R, Bravaccio C, Schneider C, et al. Serotonin transporter gene promoter variants do not explain the hyperserotoninemia in autistic children. Mol Psychiatry 2002;7:795-800.
Betancur C, Corbex M, Spelewoy C, Philippe A, Laplanche JL, Launay JM, et al. Serotonin transporter gene polymorphisms and hyperserotoninemia in autistic disorder. Mol Psychiatry 2002;7:67-71.
Jones MB, Palmour RM, Zwaigenbaum L, Szatmari P. Modifier effects in autism at the MAO-A and DBH loci. Am J Med Genet B Neuropsychiatr Genet 2004;126B:58-65.
Veenstra-VanderWeele J, Anderson GM, Cook EH Jr. Pharmacogenetics and the serotonin system: initial studies and future directions. Eur J Pharmacol 2000;410:165-181.
International Molecular Genetic Study of Autism Consortium(IMGSAC). A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J Hum Genet 2001;69:570-581.
McCauley JL, Olson LM, Dowd M, Amin T, Steele A, Blakely RD, et al. Linkage and association analysis at the serotonin transporter(SLC6A4) locus in a rigid-compulsive subset of autism. Am J Med Genet B Neuropsychiatr Genet 2004;127B:104-112.
Yonan AL, Alarcón M, Cheng R, Magnusson PK, Spence SJ, Palmer AA, et al. A genomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet 2003;73:886-897.
Conroy J, Meally E, Kearney G, Fitzgerald M, Gill M, Gallagher L. Serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population. Mol Psychiatry 2004;9:587-593.
Kim SJ, Cox N, Courchesne R, Lord C, Corsello C, Akshoomoff N, et al. Transmission disequilibrium mapping at the serotonin transporter gene(SLC6A4) region in autistic disorder. Mol Psychiatry 2002;7:278-288.
Persico AM, Militerni R, Bravaccio C, Schneider C, Melmed R, Conciatori M, et al. Lack of association between serotonin transporter gene promoter variants and autistic disorder in two ethnically distinct samples. Am J Med Genet 2000;96:123-127.
Yirmiya N, Pilowsky T, Nemanov L, Arbelle S, Feinsilver T, Fried I, et al. Evidence for an association with the serotonin transporter promoter region polymorphism and autism. Am J Med Genet 2001;105:381-386.
Zhong N, Ye L, Ju W, Brown WT, Tsiouris J, Cohen I. 5-HTTLPR variants not associated with autistic spectrum disorders. Neurogenetics 1999;2:129-131.
Coutinho AM, Oliveira G, Morgadinho T, Fesel C, Macedo TR, Bento C, et al. Variants of the serotonin transporter gene(SLC6A4) significantly contribute to hyperserotonemia in autism. Mol Psychiatry 2004;9:264-271.
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-1531.
Wu S, Guo Y, Jia M, Ruan Y, Shuang M, Liu J, et al. Lack of evidence for association between the serotonin transporter gene(SLC6A4) polymorphisms and autism in the Chinese trios. Neurosci Lett 2005;381:1-5.
Ramoz N, Reichert JG, Corwin TE, Smith CJ, Silverman JM, Hollander E, et al. Lack of evidence for association of the serotonin transporter gene SLC6A4 with autism. Biol Psychiatry 2006;60:186-191.
Cho IH, Yoo HJ, Park M, Lee YS, Kim SA. Family-based association study of 5-HTTLPR and the 5-HT2A receptor gene polymorphisms with autism spectrum disorder in Korean trios. Brain Res 2007;1139:34-41.
Yoo HJ, Cho IH, Park M, Cho E, Cho SC, Kim BN, et al. Association between PTGS2 polymorphism and autism spectrum disorders in Korean trios. Neurosci Res 2008;62:66-69.
Yoo HJ. Korean version of Autism Diagnostic Interview-Revised(ADI-R). Hakji-sa, Seoul;2007.
Yoo HJ, Kwak Y. Korean version of Autism Diagnostic Observation Schedule(ADOS). Hakji-sa, Seoul;2007.
Lange C, DeMeo DL, Laird NM.
Power and design considerations for a general
class of family-based association tests: quantitative traits. Am J Hum Genet
2002;71:1330-1341.